NICE Tackles Antibiotic Resistance In New UK Guidance
Executive Summary
New final guidance from NICE explains how best to avoid the risk of antibiotic resistance in patients with community- and hospital-acquired pneumonia.
You may also be interested in...
Gedea Champions Both Women’s Health And The Fight Against Antibiotic Resistance
Gedea Biotech is developing an antibiotic-free drug which could significantly improve the treatment of bacterial vaginosis. In Vivo spoke with CEO Annette Säfholm, a 2021 Rising Leader.
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.
Post-Brexit UK Risks Being ‘Left Out In The Cold’ As EU Coordinates Action On Shortages
The UK is not alone in experiencing drug shortages, as data from across Europe show, but its departure from the EU makes it more difficult to respond to supply chain pressures, according to new research.